Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oraloncology.2024.106831 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "cancer
4
"cancer cell-derived
4
cell-derived extracellular
4
extracellular vesicles
4
vesicles drive
4
drive pre-metastatic
4
pre-metastatic niche
4
niche formation
4
formation lymph
4
lymph node
4
Similar Publications
Corrigendum to "PS10.16 ACTIVITY IN THE SALIVA OF rhTSH AND THW THYROID CANCER PATIENTS TREATED WITH IODINE-131" [Phys. Med. 125(Supplement 1) (2024) 104229].
Phys Med
December 2024
Hospital Povisa S.A., Vocational Training Center, Vigo, Spain.
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].
Cancer Treat Rev
December 2024
Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Electronic address:
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].
J Thromb Haemost
December 2024
Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA.
Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 2024, Pages 338-347.e1].
J Thorac Cardiovasc Surg
December 2024
Duke Cancer Institute, Duke University Medical Center, Durham, NC.
Corrigendum to "Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer" [Abdominal Radiology (2024) 49:163-172.].
Abdom Radiol (NY)
December 2024
Department of Radiology, University of Washington, Seattle, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!